Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02118649 · ClinicalTrials.gov registry record · NA
Enhancing Behavior and Brain Response to Visual Targets Using a Computer Game
A NA study of Neurodevelopmental Disorders, sponsored by Yale University.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02118649: Active NA study of Neurodevelopmental Disorders, sponsored by Yale University.
NCT02118649 is a NA study of Neurodevelopmental Disorders that is active but no longer recruiting, run by Yale University. The registered enrollment target is 100 participants, below the 578-participant average among 27 other Neurodevelopmental Disorders trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02118649, a NA study of Neurodevelopmental Disorders, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants will play a computer game that is controlled by their gaze patterns and designed to direct attention their attention to specific on-screen targets. Visual attention to targets will be rewarded. Both visual behavior and brain response will be recorded during game play. It is hypothesized that that, over the course of the game, relative to baseline, participants will show (a) increased looking to targets, (b) decreased response time to targets, and (c) enhanced, more efficient neural response to visual cues. It is hypothesized that clinical variability will associate with visual attention and brain response.
Conditions Studied
Interventions
- BEHAVIORAL Game
Study Locations (1)
Connecticut
- Yale Child Study Center - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-04-01 |
| Est. Completion | 2026-04 |
| Phase | NA |
What the registry record for NCT02118649 still lists
NCT02118649 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 578-participant average among 27 other Neurodevelopmental Disorders trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Neurodevelopmental Disorders appearing as the primary indexed condition, and to 1 intervention - of which Game is the first listed.
NCT02118649 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT02118649 about?
NCT02118649 is a clinical study titled "Enhancing Behavior and Brain Response to Visual Targets Using a Computer Game". Participants will play a computer game that is controlled by their gaze patterns and designed to direct attention their attention to specific on-screen targets. Visual attention to targets will be rewarded. Both visual behavior and brain response will be recorded during game play. It is hypothesize...
What is the current status of trial NCT02118649?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2014-04-01. Estimated completion is 2026-04.
What conditions does trial NCT02118649 study?
This clinical trial studies the following conditions: Neurodevelopmental Disorders.
What interventions are being tested in trial NCT02118649?
The interventions under investigation include: Game (BEHAVIORAL).
Who is sponsoring clinical trial NCT02118649?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02118649 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurodevelopmental Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02118649's enrollment target sits among peer trials
100 17th of 27 higher than 10 of 27 other Neurodevelopmental Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neurodevelopmental Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
School-based Paraeducator Education for Engagement at Recess
RECRUITING · NA
-
Word Learning From Parentese in Autistic Children
RECRUITING · NA
-
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
RECRUITING · NA
-
Genetic Inclusion by Virtual Evaluation
RECRUITING · NA
-
AIRB-4: Self-Determined Learning Model of Instruction
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI